Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a new site build; no study content or critical information appears to be altered.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page's revision indicator has been updated from v3.6.0 to v3.6.2. This reflects a metadata update rather than any substantive changes to trial information or content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now includes new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and shows 'No longer looking for participants' in recruitment. The 'Intervention / Treatment' header has been changed to 'Intervention/Treatment', and the footer revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the page. This change does not alter the study details or any visible content.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new platform release. This change represents a version upgrade to the ClinicalTrials.gov interface rather than any modification to study content or data.SummaryDifference0.1%

- Check78 days agoChange DetectedThis reflects an update to the site/app revision number for the page display (moving from revision v3.5.2 to v3.5.3), with no indication of any content changes to the study record.SummaryDifference0.1%

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.